Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Switzerland’s Galderma today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Dermatology specialist Galderma has FDA approval for prurigo nodularis treatment Nemluvio, one of two new drugs that it thinks will deliver blockbuster sales. The US regulator cleared the IL-31 ...

Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...

Dermatology specialist Galderma has claimed a second FDA approval ... by the FDA in the summer for the rare skin disorder prurigo nodularis – can now be used in the US to treat patients aged ...

Swiss skincare company Galderma is banking on a dermatological drug to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. The company ...

Considering taking supplements to treat prurigo nodularis? Below is a list of common natural remedies used to treat or reduce the symptoms of prurigo nodularis. Follow the links to read common ...

In addition to presenting 30 abstracts with data on prurigo nodularis, atopic dermatitis, sensiti ZUG, Switzerland, August 13, 2024--Galderma today announced that the U.S. Food and Drug ...

The lack of awareness about rare diseases like prurigo nodularis and available treatment options is anticipated to impede market growth.